Baird upgraded McKesson (NYSE:MCK) to outperform from neutral on Thursday, citing the updates the medical distributor gave ...
Shares of McKesson climbed after the drug distributor raised its fiscal-year guidance and reported strong sales growth during its fiscal second quarter. The stock was up 11%, at $610.99, in midday ...
McKesson's earnings for its fiscal 2025 second quarter exceeded expectations, despite special charges that cut into net ...
U.S. stocks are ticking higher ahead of the Federal Reserve’s announcement coming later in the afternoon about what it will ...
Drug distributor McKesson Corp raised its annual profit forecast on Wednesday, driven by increased sales in its U.S.
Steve Baxter, an analyst from Wells Fargo, maintained the Hold rating on McKesson (MCK – Research Report). The associated price target ...
An arm of health care giant McKesson will pay $448,578 in back wages and interest as part of an agreement with the U.S.
Morgan Stanley analyst Erin Wright has maintained their bullish stance on MCK stock, giving a Buy rating today. Erin Wright has given his Buy ...
McKesson Medical-Surgical Inc. entered into an agreement with the Labor Department on Monday resolving employment ...
McKesson Corp (MCK) reports a 21% revenue increase and raises fiscal 2025 EPS guidance amid strategic expansions and ...
The health care giant agreed to pay $448,000 in back wages to resolve hiring discrimination allegations at a DFW facility.
McKesson Corporation (NYSE: MCK) has released its fiscal 2025 second quarter financial results. Results can be accessed on McKesson’s Investor Relatio ...